Ventrus Biosciences Liabilities:1.977M for March 31, 2013
Ventrus Biosciences Liabilities Chart
Ventrus Biosciences Historical Liabilities DataPro Data Export
There is no data for the selected date range.
|Data for this Date Range|
|March 31, 2013||1.977M|
|Dec. 31, 2012||2.746M|
|Sept. 30, 2012||2.681M|
|June 30, 2012||3.392M|
|March 31, 2012||3.853M|
|Dec. 31, 2011||2.513M|
|Sept. 30, 2011||1.183M|
|June 30, 2011||2.090M|
|March 31, 2011||1.606M|
|Dec. 31, 2010||2.990M|
|Sept. 30, 2010||17.54M|
|June 30, 2010||16.22M|
|March 31, 2010||14.92M|
|Dec. 31, 2009||13.53M|
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.
Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.
Simply, liabilities are the part of a company's assets that it has yet to repay back.
VTUS Liabilities Rankings
1671 of 16773
160 of 1408 in Healthcare
22 of 135 in Drug Manufacturers - Major
VTUS Liabilities Range, Past 5 Years
PR Newswire May 17